Previous close | 0.0470 |
Open | 0.0350 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0350 - 0.0474 |
52-week range | 0.0350 - 0.1950 |
Volume | |
Avg. volume | 160,005 |
Market cap | 18.422M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Continued Focus on Gross Margin Expansion Showing SuccessTORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today reported its financial results for the three months ended February 28, 2022 (“Q1 2022”) compared to the same period last year (“Q1 2021”). All financial fi
New to The Street TV Signs 12 Part Series, Featuring Lifeist Wellness, Inc. FMW Media Works’ New to The Street TV will feature Lifeist Wellness, Inc. (“Lifeist”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF) on its national and internationally syndicated television program. The series will span 12-months introducing Lifeist Wellness and in particular, its subsidiary Mikra, Cellular Sciences and its current and future cellular wellness products - www.newtothestreet.com and www.lifeist.com NEW YO
- Company Signs Contract for 12 Part TV Series Across Syndicated Television Networks - - OakHill Financial to provide targeted investor outreach and increased capital markets advisory services - TORONTO, April 22, 2022 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today announced an init